Skip to main content
. 2020 May 6;2020:2563508. doi: 10.1155/2020/2563508

Table 2.

Clinical characteristics of the patients at discharge.

All HF patients (n = 72) With events (n = 27) Without events (n = 45) P value
Physical examination
Heart rate (beats/min) 80.3 (9.3) 82.3 (9.1) 79.2 (9.9) 0.19
Systolic BP (mmHg) 133.5 (16.6) 136.8 (20.8) 131.5 (13.3) 0.19
Diastolic BP (mmHg) 77.3 (13.6) 76.5 (13.6) 77.8 (13.8) 0.70
Medication at discharge
ACEI/ARBs [n (%)] 56 (77.8) 22 (81.5) 34 (75.6) 0.77
Aldosterone antagonist [n (%)] 52 (72.2) 20 (74.1) 32 (71.1) 0.96
CCB [n (%)] 29 (40.3) 12 (44.4) 17 (37.8) 0.76
Beta-blockers [n (%)] 43 (59.7) 18 (66.7) 25 (55.6) 0.49
Loop diuretics/HCT [n (%)] 58 (80.6) 25 (92.6) 33 (73.3) 0.09
Digoxin [n (%)] 37 (51.4) 13 (48.1) 24 (53.3) 0.86
Statins [n (%)] 60 (83.3) 24 (88.9) 36 (80.0) 0.51
Antithrombotics [n (%)] 58 (80.6) 21 (77.8) 37 (82.2) 0.88

Continuous variables are presented as median (interquartile range) or mean (standard deviation). Categorical variables are expressed as number (percentages). ACEI/ARB: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers; BP: blood pressure; CCB: calcium channel blocker; HCT: hydrochlorothiazide.